These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7257272)

  • 1. [Correlations of hyperlipidemia and myocardial function in the chronic form of ischemic heart disease].
    Pentiuk AA; Morozova RZ; Kaminker LI
    Vrach Delo; 1981 May; (5):75-7. PubMed ID: 7257272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complex evaluation of functional state of the myocardium and its importance for disability evaluation of patients with ischemic heart disease].
    Kogan BM; Sokolova DA; Kuz'mishin LE
    Ter Arkh; 1976; 48(6):18-24. PubMed ID: 973184
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microvascular reactivity, tissue blood flow and hyperlipidemia in ischemic heart disease].
    Shchepotin IuB
    Vrach Delo; 1980 Sep; (9):50-2. PubMed ID: 7423950
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ischemic heart disease and hyperlipoproteinemia].
    Voslárová Z; Kucerová L; Papezová R
    Cas Lek Cesk; 1973 Oct; 112(43):1325-30. PubMed ID: 4753745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Activity of the kallikrein-kinin system of the blood in patients with chronic ischemic heart disease].
    Proniv LN
    Vrach Delo; 1986 May; (5):65-7. PubMed ID: 3637040
    [No Abstract]   [Full Text] [Related]  

  • 6. [Importance of a functional assessment of the cardiovascular system for the medical disability expert evaluation of ischemic heart disease patients].
    Kogan BM; Kuz'mishin LE; Mitronin SE
    Sov Med; 1982; (5):95-9. PubMed ID: 7112235
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lipid metabolism indices in patients with chronic ischemic heart disease and psychopathologic syndromes].
    Lazarev VI; Beliakova NA
    Vrach Delo; 1983 Oct; (10):12-5. PubMed ID: 6359687
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for cholesterol management: recommendations of the National Cholesterol Education Program's Adult Treatment Panel II.
    Grundy SM
    Heart Dis Stroke; 1994; 3(3):123-7. PubMed ID: 8044423
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic compensation of exertion in ischemic heart disease].
    Chmir VP
    Vrach Delo; 1980 Aug; (8):55-8. PubMed ID: 7415130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term administration of tyquanol in the treatment of patients with ischemic heart disease in combination with hyperlipidemia].
    Panchenko VM; Ershov AA; Isaev VA
    Klin Med (Mosk); 2003; 81(3):40-2. PubMed ID: 12698850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study.
    Batista J; Stüsser R; Saéz F; Pérez B
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):134-7. PubMed ID: 8705091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of the course of ischemic heart disease in thyroid hypofunction].
    Tursunov SIu; Makhmudov B; Dalimov Kh; Iagudaev AM; Khusainov KD
    Kardiologiia; 1979 Mar; 19(3):28-33. PubMed ID: 430955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Right ventricular function in ischemic heart disease].
    Horák J; Fabián J; Ouhrabková R
    Cas Lek Cesk; 1987 Jan; 126(2):44-9. PubMed ID: 3802162
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperlipoproteinemia in patients hospitalized for ischemic coronary disease and myocardial infarct].
    Cisarik F; Gavalec M; Zánová J; Hrbánová Z
    Vnitr Lek; 1981 Feb; 27(2):137-41. PubMed ID: 7467156
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genealogy and the clinical manifestations of familial hyperlipidemias types IIa and IIb].
    Lipovetskiĭ BM
    Ter Arkh; 1993; 65(12):34-8. PubMed ID: 8146768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of the microcirculation and tissue oxygen diffusion in hyperlipidemias and ischemic heart disease].
    Ivanov SN; Lipovetskiĭ BM
    Fiziol Cheloveka; 1990; 16(2):154-6. PubMed ID: 2373307
    [No Abstract]   [Full Text] [Related]  

  • 17. [Risk factors of ischemic heart disease and lipid metabolism in cardiorespiratory diseases].
    Avdeeva EV; Koval'skaia EA; Vostrikova OG
    Klin Med (Mosk); 2000; 78(3):25-8. PubMed ID: 10790960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in serum lipids and lipoprotein lipids detected by coronary angiography in ischemic heart disease].
    Romics L; Keltai M; Palik I
    Orv Hetil; 1984 Feb; 125(8):443-8. PubMed ID: 6700985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of physical work capacity in cardiac patients].
    Benestad AM
    Tidsskr Nor Laegeforen; 1969 Jul; 89(14):1189-91. PubMed ID: 5797021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.